Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bezafibrate[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[8] 20, 93, 94, 160, 296, 316, 324, 344 💬
2Bezafibrate (INN 3968)[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 324 💬
3Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8 Days - 7 Years----[10] 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
4Diagnostic Test: Obtaining Dry Blood Spots From Healthy Children Aged 8-18 Years----[10] 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
5Diagnostic Test: Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days)----[10] 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
6Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 - 18 years)----[10] 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
7Diagnostic Test: Obtaining Dry Blood Spots From High-risk childrens (Aged 8 Days- 7 years)----[10] 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
8Diagnostic Test: Obtaining Dry Blood Spots From High-risk Newborns (Aged 1-7 Days)----[10] 244, 247, 251, 255, 316, 321, 322, 324, 337, 344 💬
9Elamipretide[1] Elamipretide[2] Elamipretide ,
Elamipretide hydrochloride 💬
--[3] 18, 21, 324 💬
10Triheptanoin[1] Triheptanoin[1] Triheptanoin 💬 --[12] 2, 8, 65, 149, 156, 248, 256, 257, 317, 318, 324, 344 💬